Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Shares Issued (2022 - 2025)

Coya Therapeutics' Shares Issued history spans 4 years, with the latest figure at $19137.0 for Q3 2025.

  • For Q3 2025, Shares Issued fell 99.61% year-over-year to $19137.0; the TTM value through Sep 2025 reached $9.1 million, up 84.05%, while the annual FY2024 figure was $14.0 million, 1.73% down from the prior year.
  • Shares Issued for Q3 2025 was $19137.0 at Coya Therapeutics, roughly flat from $19137.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $14.3 million in Q1 2023 and bottomed at -$1.4 million in Q2 2024.
  • The 4-year median for Shares Issued is $689797.0 (2024), against an average of $3.5 million.
  • The largest annual shift saw Shares Issued skyrocketed 9019084.18% in 2023 before it plummeted 99.61% in 2025.
  • A 4-year view of Shares Issued shows it stood at $158.0 in 2022, then surged by 9019084.18% to $14.3 million in 2023, then crashed by 36.42% to $9.1 million in 2024, then tumbled by 99.79% to $19137.0 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Shares Issued are $19137.0 (Q3 2025), $19137.0 (Q1 2025), and $9.1 million (Q4 2024).